FDA: Prenatal use of antipsychotics might pose risk to newborns - Related Stories - AANP SmartBrief
Links shared publicly online about this topic.
- 485total visits
FDA: Prenatal use of antipsychotics might pose risk to newborns - Related Stories - AANP SmartBrief
The FDA warned that taking atypical antipsychotics during the third trimester of pregnancy might cause abnormal muscle movement and withdrawal symptoms among newborns. The warning label for such drugs was upgraded to mention the risk, the agency said.
View full resource at smartbrief.com
Tags: Muscle, Children's Health, Pregnancy, FDA, Nursing Professions, Nurse, Nursing
Most Recently Shared on February 23, 2011 at 3:52 pm By:
FDA: #Prenatal use of #antipsychotics might pose #risk to newborns. http://sbne.ws/r/6QcI #nurse #OB #hcr #pharm
Advertisement
